Four-year follow-up of patients with imatinib-resistant or intolerant chronic myeloid leukemia receiving dasatinib: efficacy and safety
Crossref DOI link: https://doi.org/10.1007/s11684-018-0639-7
Published Online: 2019-06-11
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Xiaojun
Jiang, Qian
Hu, Jianda
Li, Jianyong
Jin, Jie
Meng, Fanyi
Shen, Zhixiang
Liu, Ting
Wu, Depei
Wang, Jianmin
Wang, Jianxiang
Text and Data Mining valid from 2019-06-01
Version of Record valid from 2019-06-01
Article History
Received: 30 March 2017
Accepted: 27 January 2018
First Online: 11 June 2019